Courtland Longest is a product management and marketing leader who has spent the last decade in the precision medicine space. During that time, he has focused on discovering, building, and commercially launching precision medicine tests that oncologists use to treat their patients more precisely. These have included live-cell chemosensitivity tests, molecular biomarker tests, and proprietary multi-gene “signatures” that predict a patient’s risk of cancer recurrence. Courtland joined UPMC Enterprises in fall 2015 and serves as the Director of Product for Precision Medicine. He is excited by the potential to create new products and companies that leverage the large UPMC’s large patient population, clinical expertise, and significant genomics and machine learning capabilities.